Balance Sheet
Accounts PayablesCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Non-Current Deferred Tax Liability: 2018-2025

Historic Non-Current Deferred Tax Liability for Dr Reddys Laboratories (RDY) over the last 8 years, with Mar 2025 value amounting to $165.0 million.

  • Dr Reddys Laboratories' Non-Current Deferred Tax Liability rose 1400.00% to $165.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $165.0 million, marking a year-over-year increase of 1400.00%. This contributed to the annual value of $165.0 million for FY2025, which is 1400.00% up from last year.
  • According to the latest figures from FY2025, Dr Reddys Laboratories' Non-Current Deferred Tax Liability is $165.0 million, which was up 1,400.00% from $11.0 million recorded in FY2024.
  • Over the past 5 years, Dr Reddys Laboratories' Non-Current Deferred Tax Liability peaked at $165.0 million during FY2025, and registered a low of $1.0 million during FY2022.
  • For the 3-year period, Dr Reddys Laboratories' Non-Current Deferred Tax Liability averaged around $62.0 million, with its median value being $11.0 million (2024).
  • As far as peak fluctuations go, Dr Reddys Laboratories' Non-Current Deferred Tax Liability plummeted by 80.00% in 2022, and later skyrocketed by 1,400.00% in 2025.
  • Dr Reddys Laboratories' Non-Current Deferred Tax Liability (Yearly) stood at $5.0 million in 2021, then slumped by 80.00% to $1.0 million in 2022, then soared by 900.00% to $10.0 million in 2023, then grew by 10.00% to $11.0 million in 2024, then surged by 1,400.00% to $165.0 million in 2025.